Skip to main content
. 2009 Oct 27;6(10):e1000173. doi: 10.1371/journal.pmed.1000173

Table 3. Lifetime costs, life expectancy, and cost-effectiveness of interventions to prevent LTFU in Aconda centers, Côte d'Ivoire.

Effectiveness of Intervention (% Reduction in LTFU) Discounted per Person Lifetime Costs Discounted per Person Life Expectancy (Mo) Cost-Effectiveness Ratio (US$/YLS)
No intervention US$8,800 131.0
US$22 intervention (/person/year)
10 US$9,100 132.4 US$3,100
25 US$9,300 134.4 US$1,800
50 US$9,600 137.9 US$1,400
75 US$9,900 141.3 US$1,200
US$41 intervention (/person/year)
10 US$9,300 132.4 US$4,900
25 US$9,500 134.4 US$2,600
50 US$9,800 137.9 US$1,800
75 US$10,100 141.3 US$1,500
US$53 intervention (/person/year)
10 US$9,500 132.4 US$6,100
25 US$9,600 134.4 US$3,000
50 US$9,900 137.9 US$2,000
75 US$10,200 141.3 US$1,700
US$77 intervention (/person/year)
10 US$9,700 132.4 US$8,400
25 US$9,900 134.4 US$4,000
50 US$10,200 137.9 US$2,500
75 US$10,500 141.3 US$2,000

Baseline LTFU rate is 18%. All cost-effectiveness ratios are computed on an incremental basis using the “no intervention” strategy as the comparator. See Methods and Table 1 for details about each intervention.